Re: Bernard Pope, Gahee Park, Edmund Lau, et al. Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Prostate Cancer. Eur Urol 2024;85:407-10.
作者信息
Zhao Tingting, Jin Chengqi, Yang Bin
机构信息
Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Tongji University School of Life Sciences and Technology, Shanghai, China.
出版信息
Eur Urol Open Sci. 2024 Aug 2;67:60-61. doi: 10.1016/j.euros.2024.06.018. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Re: Bernard Pope, Gahee Park, Edmund Lau, et al. Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Prostate Cancer. Eur Urol 2024;85:407-10.回复：伯纳德·波普、朴佳熙、刘埃德蒙等。循环肿瘤DNA的超灵敏检测可富集临床前列腺癌复发风险较高的患者。《欧洲泌尿外科杂志》2024年；85卷：407 - 410页。
Eur Urol Open Sci. 2024 Aug 2;67:60-61. doi: 10.1016/j.euros.2024.06.018. eCollection 2024 Sep.
3
Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.循环肿瘤DNA的超灵敏检测可富集临床局限性前列腺癌复发风险较高的患者。
Eur Urol. 2024 Apr;85(4):407-410. doi: 10.1016/j.eururo.2024.01.002. Epub 2024 Feb 19.
4
Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025: Re: Firas Abdollah, Nazareno Suardi, Cesare Cozzarini, et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. Eur Urol 2013;63:998-1008.回复：萨诺伊·普嫩恩、马修·R·库珀伯格、安东尼·V·达米科等。前列腺癌初次治疗后生化复发的管理：文献系统综述。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2013.05.025：回复：菲拉斯·阿卜杜拉、纳扎雷诺·苏阿尔迪、切萨雷·科扎里尼等。前列腺癌根治术后辅助放疗最佳候选者的选择：长期生存分析。《欧洲泌尿外科杂志》2013年；63卷：998 - 1008页。
Eur Urol. 2013 Nov;64(5):e102. doi: 10.1016/j.eururo.2013.07.029. Epub 2013 Jul 26.
5
Re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The Use of Polymer (Hem-o-lok) clips for management of the renal hilum during laparascopic nephrectomy. Eur Urol 2006; 49:816-9. Eur Urol 2007;51:572-3.回复：H. 鲍默特等人。腹腔镜肾切除术期间使用聚合物（Hem-o-lok）夹处理肾蒂。《欧洲泌尿外科杂志》2006年；49卷：816 - 819页，以及P.L. 斯坦伯格等人。回复：H. 鲍默特等人。腹腔镜肾切除术期间使用聚合物（Hem-o-lok）夹处理肾蒂。《欧洲泌尿外科杂志》2006年；49卷：816 - 819页。《欧洲泌尿外科杂志》2007年；51卷：572 - 573页。
Eur Urol. 2007 Feb;51(2):574-5; author reply 575-6. doi: 10.1016/j.eururo.2006.09.021. Epub 2006 Oct 12.
6
Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1-3.
Eur Urol. 2017 Apr;71(4):e105-e106. doi: 10.1016/j.eururo.2016.09.021. Epub 2016 Sep 20.
7
Reply to M.V. Meng's Letter to the Editor re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9. Eur Urol 2007;51:572-3.回复M.V. 孟致编辑的信，信中涉及H. 鲍默特等人的“腹腔镜肾切除术期间使用聚合物（Hem-o-lok）夹处理肾蒂”（《欧洲泌尿外科杂志》2006年；49：816 - 9）以及P.L. 斯坦伯格等人的相关内容（信中涉及H. 鲍默特等人的“腹腔镜肾切除术期间使用聚合物（Hem-o-lok）夹处理肾蒂”，《欧洲泌尿外科杂志》2006年；49：816 - 9）。《欧洲泌尿外科杂志》2007年；51：572 - 3 。
Eur Urol. 2007 May;51(5):1449. doi: 10.1016/j.eururo.2007.01.011. Epub 2007 Jan 10.
8
Re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71: Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?回复：伯纳德·H·博chner、圭多·达尔巴尼、卡里姆·H·马尔祖克等人。比较开放性根治性膀胱切除术与机器人辅助腹腔镜根治性膀胱切除术的随机试验：肿瘤学结果。《欧洲泌尿外科杂志》2018年；74卷：465 - 471页：癌症复发模式真的可以归因于手术方式吗？
Eur Urol. 2019 May;75(5):e137. doi: 10.1016/j.eururo.2019.01.036. Epub 2019 Feb 2.
9
Re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667-75: How Does Circulating DNA Reach the Blood Stream?回复：吉利安·范德克尔霍夫、维尔纳·J·施特鲁斯、马蒂·安娜拉等。循环肿瘤DNA丰度及其在新发转移性前列腺癌中的潜在应用。《欧洲泌尿外科杂志》2019年；75:667 - 75：循环DNA是如何进入血流的？
Eur Urol. 2019 Sep;76(3):e69-e72. doi: 10.1016/j.eururo.2019.05.035. Epub 2019 Jun 6.
10
Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Riccardo Autorino, Homayoun Zagar, Mirandolino B. Mariano, et al. Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis. Eur Urol 2015;68:86-94; Re: Matthew Bultitude, Ben Challacombe. Simple Prostatectomy: A Step Too Far for Laparoscopy? Eur Urol 2015;68:95-6. Eur Urol 2015;68:e7-8.回复弗朗切斯科·蒙托西和乔治·甘达利亚致编辑的信，内容涉及：里卡尔多·奥托里诺、霍马尤恩·扎加尔、米兰多利诺·B·马里亚诺等人。机器人辅助与腹腔镜单纯前列腺切除术的围手术期结果：一项欧美多机构分析。《欧洲泌尿外科杂志》2015年；68卷：86 - 94页；回复：马修·布尔蒂德、本·查拉科姆比。单纯前列腺切除术：腹腔镜手术走得太远了？《欧洲泌尿外科杂志》2015年；68卷：95 - 96页。《欧洲泌尿外科杂志》2015年；68卷：e7 - 8页。
Eur Urol. 2015 Jul;68(1):e9-10. doi: 10.1016/j.eururo.2015.01.024. Epub 2015 Feb 7.
本文引用的文献
1
Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.循环肿瘤DNA的超灵敏检测可富集临床局限性前列腺癌复发风险较高的患者。
Eur Urol. 2024 Apr;85(4):407-410. doi: 10.1016/j.eururo.2024.01.002. Epub 2024 Feb 19.
2
Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer.循环肿瘤DNA与组织互补检测转移性激素敏感性前列腺癌中的基因组改变。
iScience. 2024 Jan 17;27(2):108931. doi: 10.1016/j.isci.2024.108931. eCollection 2024 Feb 16.
3
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.通过靶向多区域测序对异质性局限性前列腺癌进行肿瘤突变的无细胞 DNA 检测。
JCO Precis Oncol. 2021 Apr 27;5. doi: 10.1200/PO.20.00428. eCollection 2021.
4
Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression.检测临床局限性前列腺癌患者血浆中的 ctDNA 与疾病的快速进展相关。
Genome Med. 2020 Aug 17;12(1):72. doi: 10.1186/s13073-020-00770-1.
5
Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer.局限性前列腺癌中循环肿瘤DNA的低丰度
JCO Precis Oncol. 2019;3. doi: 10.1200/PO.19.00176. Epub 2019 Sep 9.
Zotero 插件